B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 620 KRW 2.67%
Market Cap: 471.2B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Capital Expenditures Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Capital Expenditures
-â‚©4.5B
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Capital Expenditures
-â‚©350.4B
CAGR 3-Years
15%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
SK Bioscience Co Ltd
KRX:302440
Capital Expenditures
-â‚©50.3B
CAGR 3-Years
-70%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Capital Expenditures
-â‚©34.1B
CAGR 3-Years
8%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Capital Expenditures
-â‚©27.5B
CAGR 3-Years
11%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Capital Expenditures
-â‚©33.4B
CAGR 3-Years
-35%
CAGR 5-Years
-28%
CAGR 10-Years
N/A

See Also

What is BioNote Inc's Capital Expenditures?
Capital Expenditures
-4.5B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Capital Expenditures amounts to -4.5B KRW.

What is BioNote Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
45%

Over the last year, the Capital Expenditures growth was 89%. The average annual Capital Expenditures growth rates for BioNote Inc have been 45% over the past three years .

Back to Top